DUBOIS, MARCO
 Distribuzione geografica
Continente #
EU - Europa 5.805
NA - Nord America 262
AS - Asia 63
OC - Oceania 2
Totale 6.132
Nazione #
IT - Italia 5.702
US - Stati Uniti d'America 256
SE - Svezia 56
CN - Cina 22
IN - India 15
NL - Olanda 11
DE - Germania 9
FI - Finlandia 7
GB - Regno Unito 7
HK - Hong Kong 7
FR - Francia 6
CA - Canada 5
SG - Singapore 5
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
IR - Iran 3
AU - Australia 2
IE - Irlanda 2
ES - Italia 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
RU - Federazione Russa 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 6.132
Città #
Cagliari 5.665
Nyköping 48
Fairfield 39
Chandler 35
Ashburn 24
Boardman 14
Houston 14
Shanghai 13
New York 12
Seattle 12
Pune 11
San Diego 11
Woodbridge 11
Boston 10
Rome 10
Wilmington 9
Amsterdam 8
Helsinki 7
Cambridge 6
Toronto 5
Dong Ket 4
Hefei 4
Hong Kong 4
Menlo Park 4
Romainville 4
Peristeri 3
San Cipriano d'Aversa 3
Delhi 2
Don Mueang 2
Islington 2
Los Angeles 2
Naples 2
Olbia 2
Paris 2
San Francisco 2
San Giorgio a Cremano 2
Sydney 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Ann Arbor 1
Bilbao 1
Chandigarh 1
Exeter 1
Frattamaggiore 1
Hamburg 1
Heidelberg 1
Jacksonville 1
London 1
Miami Beach 1
Moscow 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Norwalk 1
Port-of-spain 1
Pozzuoli 1
Rockville 1
Shenzhen 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Trumbull 1
Washington 1
Zhengzhou 1
Totale 6.041
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.066
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 581
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 464
Molecular-driven treatment for biliary tract cancer: the promising turning point 454
Uncovering key targets of success for immunotherapy in pancreatic cancer 400
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 393
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 389
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 340
Immune Checkpoint Inhibitors in the Treatment of HCC 327
BRCA-mutant pancreatic ductal adenocarcinoma 321
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 257
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 150
null 27
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 5
Totale 6.174
Categoria #
all - tutte 9.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/20221.147 53 48 3 25 40 84 56 120 69 95 188 366
2022/20232.498 275 375 260 167 184 233 115 157 164 292 182 94
2023/20241.570 79 56 80 107 166 354 365 160 100 99 4 0
Totale 6.174